Not Signed In - VIVUS Announces Positive Phase 3 Clinical Trial Results For Evamist(TM) - The First Transdermal Spray For The Treatment Of Menopausal Symptoms
Sat, 06 May 2006 06:00 AM EST
... VIVUS, Inc.(Nasdaq: VVUS) today announced positive results from the pivotal Phase 3clinical trial of Evamist(TM). VIVUS' investigational estradiol metereddose transdermal spray is being developed for the treatment of vasomotorsymptoms associated with menopause. The study showed a statisticallysignificant reduction in the number and severity of moderate and severe hotflashes for all three doses tested... click link for more info. ...
Related Topics
- Clinical Trials
- Ovarian Cancer
- Depression
- Pancreatic Cancer
- Pharmacology
- Trastuzumab
- Psychopharmacology
- The signs and symptoms related to the central nervous system may be irreversible if treatment is not begun within 6 months of when these symptoms begin.
- Tb
- Azelastine Nasal Spray
- Testosterone Transdermal
- Desmopressin Nose Spray
- Crohn's Disease
- Tarceva
- Mometasone Nasal Spray
- Nicotine Skin Patches
- Nitroglycerin Spray
- Pneumonia
- Calcitonin Salmon Nasal Spray
- Western/Clinical Treatment and Therapy
email this page
print this page
bookmark this page
feedback on this page
